Keystone Bio, Inc. — Form D

Keystone Bio, Inc. of ST. LOUIS, MO, a company, filed a Form D exempt-offering notice with the SEC on 2019-04-29. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2019-04-29
• Form: D
• Accession: 0001567619-19-009297
• Industry: Biotechnology
• Exemptions: 06c
• Total offering: $5.0M
• Amount sold: $5.0M
• Minimum investment: $5.0M
• Investors: 1
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-338327

Issuer

• Name: Keystone Bio, Inc.
• CIK: 0001774842
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2018
• Address: CAMBRIDGE INNOVATION CENTER 4220 DUNCAN AVE., SUITE 200, ST. LOUIS, MO, 63110
• Phone: 314-471-9655

Officers, directors & promoters (9)

More

• CIK 1774842 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search